FDA Approved: RAMELTEON — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ramelteon by Actavis Pharma, Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Ramelteon (Rozerem) (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)